Mechanism Investigation of Selinexor Combined With Lenalidomide and Rituximab in the Treatment of Diffuse Large B-cell Lymphoma
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:June 28, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Lymphoma, Large B-Cell, DiffuseLast Updated:June 28, 2023Not yet recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:July 11, 2023Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:March 26, 2024Recruiting
Condition(s):Lymphoma; Lymphoma, Large B-Cell, DiffuseLast Updated:February 23, 2024Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:June 23, 2022Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:July 11, 2023Recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:December 23, 2022Recruiting
Condition(s):Diffuse Large B-Cell Lymphoma, Unspecified SiteLast Updated:February 20, 2024Recruiting
Condition(s):Diffuse Large B-cell LymphomaLast Updated:October 12, 2022Not yet recruiting
Condition(s):Diffuse Large B Cell LymphomaLast Updated:August 28, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.